Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...
Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...
BOSTON, Jan. 10, 2025 /PRNewswire/ -- According to the latest study from BCC Research, " Chronic Disease Management: Therapeutics, Device Technologies, and Global Markets ," is projected to grow from ...
Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions BOSTON, Jan. 10, 2025 /PRNewswire/ -- According ...
Eli Lilly is expanding its private financing ambitions, partnering with venture capital firm Andreessen Horowitz on a new ...